1-4 of 4
Andre T. Baron
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Soluble Epidermal Growth Factor Receptor (SEG-FR) and Cancer Antigen 125 (CA125) as Screening and Diagnostic Tests for Epithelial Ovarian Cancer

Available to Purchase
Andre T. Baron, Cecelia H. Boardman, Jacqueline M. Lafky, Alfred Rademaker, Dachao Liu, David A. Fishman, Karl C. Podratz, Nita J. Maihle
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2005) 14 (2): 306–318.
https://doi.org/10.1158/1055-9965.EPI-04-0423
Published: 25 February 2005
View articletitled, Soluble Epidermal Growth Factor Receptor (SEG-FR) and Cancer Antigen 125 (CA125) as Screening and Diagnostic Tests for Epithelial Ovarian Cancer
Open the PDF for Soluble Epidermal Growth Factor Receptor (SEG-FR) and Cancer Antigen 125 (CA125) as Screening and Diagnostic Tests for Epithelial Ovarian Cancer in another window
Journal Articles

Soluble Epidermal Growth Factor Receptor (sEGFR/sErbB1) as a Potential Risk, Screening, and Diagnostic Serum Biomarker of Epithelial Ovarian Cancer

Available to Purchase
Andre T. Baron, Elsa M. Cora, Jacqueline M. Lafky, Cecelia H. Boardman, Marites C. Buenafe, Alfred Rademaker, Dachao Liu, David A. Fishman, Karl C. Podratz, Nita J. Maihle
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2003) 12 (2): 103–113.
Published: 01 February 2003
View articletitled, Soluble Epidermal Growth Factor Receptor (sEGFR/sErbB1) as a Potential Risk, Screening, and Diagnostic Serum Biomarker of Epithelial Ovarian Cancer
Open the PDF for Soluble Epidermal Growth Factor Receptor (sEGFR/sErbB1) as a Potential Risk, Screening, and Diagnostic Serum Biomarker of Epithelial Ovarian Cancer in another window
Journal Articles

A Preliminary Study of Serum Concentrations of Soluble Epidermal Growth Factor Receptor (sErbB1), Gonadotropins, and Steroid Hormones in Healthy Men and Women

Available to Purchase
Andre T. Baron, Jacqueline M. Lafky, Vera J. Suman, David W. Hillman, Marites C. Buenafe, Cecelia H. Boardman, Karl C. Podratz, Edith A. Perez, Nita J. Maihle
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2001) 10 (11): 1175–1185.
Published: 01 November 2001
View articletitled, A Preliminary Study of Serum Concentrations of Soluble Epidermal Growth Factor Receptor (sErbB1), Gonadotropins, and Steroid Hormones in Healthy Men and Women
Open the PDF for A Preliminary Study of Serum Concentrations of Soluble Epidermal Growth Factor Receptor (sErbB1), Gonadotropins, and Steroid Hormones in Healthy Men and Women in another window
Journal Articles

Serum sErbB1 and Epidermal Growth Factor Levels As Tumor Biomarkers in Women with Stage III or IV Epithelial Ovarian Cancer

Available to Purchase
Andre T. Baron, Jacqueline M. Lafky, Cecelia H. Boardman, Swarna Balasubramaniam, Vera J. Suman, Karl C. Podratz, Nita J. Maihle
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (1999) 8 (2): 129–137.
Published: 01 February 1999
View articletitled, Serum sErbB1 and Epidermal Growth Factor Levels As Tumor Biomarkers in Women with Stage III or IV Epithelial Ovarian Cancer
Open the PDF for Serum sErbB1 and Epidermal Growth Factor Levels As Tumor Biomarkers in Women with Stage III or IV Epithelial Ovarian Cancer in another window